NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has a beta value of 1.25 and has seen 68470.0 shares traded in the last trading session. The company, currently valued at $23.92M, closed the last trade at $1.15 per share which meant it lost -$0.02 on the day or -1.28% during that session. The NRSN stock price is -102.61% off its 52-week high price of $2.33 and 55.65% above the 52-week low of $0.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.12 million shares traded. The 3-month trading volume is 282.83K shares.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN) trade information
Sporting -1.28% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the NRSN stock price touched $1.15 or saw a rise of 3.65%. Year-to-date, NeuroSense Therapeutics Ltd shares have moved -3.75%, while the 5-day performance has seen it change -0.43%. Over the past 30 days, the shares of NeuroSense Therapeutics Ltd (NASDAQ:NRSN) have changed 11.59%. Short interest in the company has seen 0.16 million shares shorted with days to cover at 1.0.
NeuroSense Therapeutics Ltd (NRSN) estimates and forecasts
The company’s shares have gained 65.00% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -7.06% over the past 5 years. Earnings growth for 2025 is a modest 27.71% while over the next 5 years, the company’s earnings are expected to increase by 19.07%.
NRSN Dividends
NeuroSense Therapeutics Ltd is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s Major holders
The top two institutional holders are ARMISTICE CAPITAL, LLC with over 1.58 million shares worth more than $1.77 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 10.2822% of shares outstanding.
The other major institutional holder is MEITAV INVESTMENT HOUSE LTD, with the holding of over 40000.0 shares as of 2024-06-30. The firm’s total holdings are worth over $44800.0 and represent 0.2597% of shares outstanding.
